DETERMINATION OF L-735524, AN HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR, IN HUMAN PLASMA AND URINE VIA HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COLUMN-SWITCHING

被引:78
作者
WOOLF, E
AU, T
HADDIX, H
MATUSZEWSKI, B
机构
[1] Merck Research Laboratories, Department of Drug Metabolism, West Point
关键词
D O I
10.1016/0021-9673(94)00608-C
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A method for the determination of an HIV protease inhibitor, L-735 524, in human plasma and urine is described. Isolation of the analyte and the internal standard from the matrices was achieved via multiple liquid-liquid extractions with methyl tert.-butyl ether. The analyte lacks significant UV absorption at wavelengths greater than 220 nm, hence a column switching system using a cyano and C-18 column was used to further purify the extracts prior to UV detection at 210 nm. The assay has been found to be linear and has been validated over the concentration range of 5 to 500 ng/ml, when 1-ml aliquots of plasma or urine were extracted. The assay has been utilized to support human pharmacokinetic studies.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 16 条
  • [1] HIGHLY DIASTEREOSELECTIVE REACTION OF A CHIRAL, NON-RACEMIC AMIDE ENOLATE WITH (S)-GLYCIDYL TOSYLATE - SYNTHESIS OF THE ORALLY-ACTIVE HIV-1 PROTEASE INHIBITOR L-735,524
    ASKIN, D
    ENG, KK
    ROSSEN, K
    PURICK, RM
    WELLS, KM
    VOLANTE, RP
    REIDER, PJ
    [J]. TETRAHEDRON LETTERS, 1994, 35 (05) : 673 - 676
  • [2] COLUMN-SWITCHING TECHNIQUES FOR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF DRUGS IN BIOLOGICAL SAMPLES
    CAMPINSFALCO, P
    HERRAEZHERNANDEZ, R
    SEVILLANOCABEZA, A
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 619 (02): : 177 - 190
  • [3] DEVELOPMENTS IN MULTIDIMENSIONAL SEPARATION SYSTEMS
    CORTES, HJ
    [J]. JOURNAL OF CHROMATOGRAPHY, 1992, 626 (01): : 3 - 23
  • [4] DORSEY BD, 1993, 206TH NAT M AM CHEM
  • [5] MiniReview: Antiviral Targets Series, Number 1 Targets for antiviral chemotherapy: HIV-proteinase
    Dunn, B. M.
    Kay, J.
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (01) : 3 - 8
  • [6] FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS
    GALLO, RC
    SALAHUDDIN, SZ
    POPOVIC, M
    SHEARER, GM
    KAPLAN, M
    HAYNES, BF
    PALKER, TJ
    REDFIELD, R
    OLESKE, J
    SAFAI, B
    WHITE, G
    FOSTER, P
    MARKHAM, PD
    [J]. SCIENCE, 1984, 224 (4648) : 500 - 503
  • [7] HIV PROTEINASE AS A TARGET FOR DRUG-ACTION
    JOHNSTON, MI
    ALLAUDEEN, HS
    SARVER, N
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (08) : 305 - 307
  • [8] ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY
    KOHL, NE
    EMINI, EA
    SCHLEIF, WA
    DAVIS, LJ
    HEIMBACH, JC
    DIXON, RAF
    SCOLNICK, EM
    SIGAL, IS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4686 - 4690
  • [9] A STRUCTURAL MODEL FOR THE RETROVIRAL PROTEASES
    PEARL, LH
    TAYLOR, WR
    [J]. NATURE, 1987, 329 (6137) : 351 - 354
  • [10] DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS
    POPOVIC, M
    SARNGADHARAN, MG
    READ, E
    GALLO, RC
    [J]. SCIENCE, 1984, 224 (4648) : 497 - 500